Elizabeth Shpall
Department Chair Ad Interim · University of Texas M D Anderson Cancer Center
Credentials: · · · ·
History
- Present
Cell Therapy Laboratory · University of Texas M D Anderson Cancer Center
- 1984–1985
- 1980–1983
Beth Israel Hospital
Research
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Science · 2018 · 3,866 citations
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Case report · Nature Reviews Clinical Oncology · 2018 · Last of 19 authors · 1,951 citations
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
New England Journal of Medicine · 2020 · 1,804 citations
348 papers
236 papers
200 papers
171 papers · 17 as a fellow
159 papers
- KR
150 papers
149 papers
149 papers
Grants
- 1996–2031
The University of Texas MD Anderson Cancer Center Support Grant (CCSG)
National Cancer Institute · P30
Project lead · $293.2K · University of Tx Md Anderson Can Ctr
- 2011–2025
Novel Cord Blood-Derived Cellular Therapies
National Cancer Institute · P01
Contact PI · $24.4M · University of Tx Md Anderson Can Ctr
- 2003–2024
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
National Cancer Institute · P50
Contact PI · $6M · University of Tx Md Anderson Can Ctr
- 1993–2024
Hematopoietic Progenitor Cells- Cord Blood
National Cancer Institute · R01
Contact PI · $5.9M · University of Tx Md Anderson Can Ctr
Clinical trials
- 2015–2027
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
Principal investigator · Recruiting
M.D. Anderson Cancer Center
- 2013–2017
Principal investigator · Completed · Phase 3
Mesoblast, Ltd.
- 2012–2017
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
Principal investigator · Completed · Phase 1
M.D. Anderson Cancer Center
- 2007–2016
Cord Blood Expansion on Mesenchymal Stem Cells
Principal investigator · Completed · Phase 1
M.D. Anderson Cancer Center